Abstract
Malassezia furfur, a constituent of the normal human skin flora, is an etiological agent of pityriasis versicolor, which represents one of the most common human skin diseases. Under certain conditions, both exogenous and endogenous, the fungus can transition from a yeast form to a pathogenic mycelial form. To develop a standardized medium for reproducible production of the mycelial form of M. furfur to develop and optimize susceptibility testing for this pathogen, we examined and characterized variables, including kojic acid and glycine concentration, agar percentage, and pH, to generate a chemically defined minimal medium on which specific inoculums of M. furfur generated the most robust filamentation. Next, we examined the capacity of ketoconazole to inhibit the formation of M. furfur mycelial form. Both low and high, 0.01, 0.05 and 0.1 µg/ml concentrations of ketoconazole significantly inhibited filamentation at 11.9, 54.5 and 86.7%, respectively. Although ketoconazole can have a direct antifungal effect on both M. furfur yeast and mycelial cells, ketoconazole also has a dramatic impact on suppressing morphogenesis. Since mycelia typified the pathogenic form of Malassezia infection, the capacity of ketoconazole to block morphogenesis may represent an additional important effect of the antifungal.
Similar content being viewed by others
References
Barchmann T, Hort W, Krämer HJ, Mayser P (2011) Glycine as a regulator of tryptophan-dependent pigment synthesis in Malassezia furfur. Mycoses 54(1):17–22
Borelli D, Jacobs PH, Nall L (1991) Tinea versicolor: epidemiologic, clinical, and therapeutic aspects. J Am Acad Dermatol 25(2 Pt 1):300–305
Carrillo-Muñoz AJ, Rojas F, Tur-Tur C, de Los Ángeles Sosa M, Diez GO, Espada CM, Payá MJ, Giusiano G (2013) In vitro antifungal activity of topical and systemic antifungal drugs against Malassezia species. Mycoses 56(5):571–575
Crespo-Erchiga V, Florencio VD (2006) Malassezia yeasts and pityriasis versicolor. Curr Opin Infect Dis 19(2):139–147
Dorn M, Roehnert K (1977) Dimorphism of Pityrosporum orbiculare in a defined culture medium. J Invest Dermatol 69(2):244–248
Faergemann J, Aly R, Maibach HI (1983) Growth and filament production of Pityrosporum orbiculare and Pityrosporum ovale on human stratum corneum in vitro. Acta Derm Venereol 63(5):388–392
Faergemann J, Ausma J, Borgers M (2006) In vitro activity of R126638 and ketoconazole against Malassezia species. Acta Derm Venereol 86(4):312–315
Faergemann J, Borgers M, Degreef H (2007) A new ketoconazole topical gel formulation in seborrhoeic dermatitis: an updated review of the mechanism. Expert Opin Pharmacother 8(9):1365–1371
Gaitanis G, Chasapi V, Velegraki A (2005) Novel application of the Masson-Fontana stain for demonstrating Malassezia species melanin-like pigment production in vitro and in clinical specimens. J Clin Microbiol 43(8):4147–4151
Gaitanis G, Magiatis P, Hantschke M, Bassukas ID, Velegraki A (2012) The Malassezia genus in skin and systemic diseases. Clin Microbiol Rev 25(1):106–141
Garau M, Pereiro M Jr, del Palacio A (2003) In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds. Antimicrob Agents Chemother 47(7):2342–2344
Guého E, Boekhout T, Ashbee HR, Guillot J, Van Belkum A, Faergemann J (1998) The role of Malassezia species in the ecology of human skin and as pathogens. Med Mycol 36(Suppl 1):220–229
Guého E, Boekhout T, Begerow D (2010) Biodiversity, phylogeny and ultrastructure. In: Boekhout T, Guého E, Mayser P, Velegraki A (eds) Malassezia and the skin. Springer, Berlin, Heidelberg, pp 17–63
Guillot J, Breugnot C, de Barros M, Chermette R (1998) Usefulness of modified Dixon’s medium for quantitative culture of Malassezia species from canine skin. J Vet Diagn Invest 10(4):384–386
Gupta AK, Kohli Y, Summerbell RC, Faergemann J (2001) Quantitative culture of Malassezia species from different body sites of individuals with or without dermatoses. Med Mycol 39(3):243–251
Gupta AK, Batra R, Bluhm R, Boekhout T, Dawson TL Jr (2004) Skin diseases associated with Malassezia species. J Am Acad Dermatol 51(5):785–798
Gupta AK, Cooper EA, Ryder JE, Nicol KA, Chow M, Chauhry MM (2004) Optimal management of fungal infections of the skin, hair, and nails. Am J Clin Dermatol 5(4):225–237
Intayot P, Youngchim S (2016) Comparison of biochemical characterizations with PCR amplification in identification of Malassezia species isolated from pityriasis versicolor and healthy volunteers. Chiang Mai Med J 55(Suppl 1):31–43
Jena DK, Sengupta S, Dwari BC, Ram MK (2005) Pityriasis versicolor in the pediatric age group. Indian J Dermatol Venereol Leprol 71(4):259–261
Kolecka A, Khayhan K, Arabatzis M, Velegraki A, Kostrzewa M, Andersson A, Scheynius A, Cafarchia C, Iatta R, Montagna MT, Youngchim S, Cabañes FJ, Hoopman P, Kraak B, Groenewald M, Boekhout T (2014) Efficient identification of Malassezia yeasts by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). Br J Dermatol 170(2):332–341
Krisanty RI, Bramono K, Made Wisnu I (2009) Identification of Malassezia species from pityriasis versicolor in Indonesia and its relationship with clinical characteristics. Mycoses 52(3):257–262
Lambers H, Piessens S, Bloem A, Pronk H, Finkel P (2006) Natural skin surface pH is on average below 5, which is beneficial for its resident flora. Int J Cosmet Sci 28(5):359–370
Midgley G (2000) The lipophilic yeasts state of the art and prospects. Med Mycol 38(Suppl. I):9–16
Montes LE (1970) Systemic abnormalities and the intracellular site of infection of the stratum corneum. JAMA 213(9):1469–1472
Pérez Blanco M, Urbina de Guanipa O, Fernández Zeppenfeldt G, Richard de Yegres N (1990) Effect of temperature and humidity on the frequency of pityriasis versicolor. Epidemiological study in the state of Falcón, Venezuela. Invest Clin 31(3):121–128
Prohic A, Jovovic Sadikovic T, Krupalija-Fazlic M, Kuskunovic-Vlahovljak S (2016) Malassezia species in healthy skin and in dermatological conditions. Int J Dermatol 55(5):494–504
Rao GS, Kuruvilla M, Kumar P, Vinod V (2002) Clinico-epidermiological studies on tinea versicolor. Indian J Dermatol Venereol Leprol 68(4):208–209
Rincón S, Cepero de García MC, Espinel-Ingroff A (2006) A modified Christensen’s urea and CLSI broth microdilution method for testing susceptibilities of six Malassezia species to voriconazole, itraconazole, and ketoconazole. J Clin Microbiol 44(9):3429–3431
Rojas FD, Sosa Mde L, Fernández MS, Cattana ME, Córdoba SB, Giusiano GE (2014) Antifungal susceptibility of Malassezia furfur, Malassezia sympodialis, and Malassezia globosa to azole drugs and amphotericin B evaluated using a broth microdilution method. Med Mycol 52(6):641–646
Saadatzadeh MR, Ashbee HR, Holland KT, Ingham E (2001) Production of the mycelial phase of Malassezia in vitro. Med Mycol 39(6):487–493
Savin R (1996) Diagnosis and treatment of tinea versicolor. J Fam Pract 43(2):127–132
Scheinfeld N (2008) Ketoconazole: a review of a workhorse antifungal molecule with a focus on new foam and gel formulations. Drugs Today (Barc) 44(5):369–380
Schwartz RA (2004) Superficial fungal infections. Lancet 364(9440):1173–1182
Sharma A, Rabha D, Choraria S et al (2016) Clinicomycological profile of pityriasis versicolor in Assam. Indian J Pathol Microbiol 59(2):159–165
Sunenshine PJ, Schwartz RA, Janniger CK (1998) Tinea versicolor. Int J Dermatol 37(9):648–655
Tajima M, Sugita T, Harada S et al (2006) Detection of hyphae specific genes from Malassezia species using Megasort®. Nippon Ishinkin Gakkai Zasshi 47(Suppl 1):70
Velegraki A, Alexopoulos EC, Kritikou S, Gaitanis G (2004) Use of fatty acid RPMI 1640 media for testing susceptibilities of eight Malassezia species to the new triazole posaconazole and to six established antifungal agents by a modified NCCLS M27–A2 microdilution method and Etest. J Clin Microbiol 42(8):3589–3593
Youngchim S, Nosanchuk JD, Pornsuwan S, Kajiwara S, Vanittanakom N (2013) The role of L-DOPA on melanization and mycelial production in Malassezia furfur. PLoS One 8(6):e63764
Acknowledgements
This study was financially supported by the Research Fund of the Faculty of Medicine, Chiang Mai University, Chiang Mai, 50200, Thailand. JDN is partly supported by NIH AI52733.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there are no conflicts of interest.
Rights and permissions
About this article
Cite this article
Youngchim, S., Nosanchuk, J.D., Chongkae, S. et al. Ketoconazole inhibits Malassezia furfur morphogenesis in vitro under filamentation optimized conditions. Arch Dermatol Res 309, 47–53 (2017). https://doi.org/10.1007/s00403-016-1701-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-016-1701-4